Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to compare the use of calcipotriol plus betamethasone
dipropionate gel with betamethasone dipropionate in the gel vehicle, calcipotriol in the gel
vehicle and the gel vehicle alone when used in patients with psoriasis vulgaris on the trunk
and/or limbs. Patients will be treated once daily for up to 8 weeks.
The primary response criterion is the number of patients with controlled disease at week 8.